A Combinatorial Strategy for Targeting BRAFV600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)

JOURNAL ARTICLE published 15 April 2020 in Clinical Cancer Research

Research funded by intramural research program (1ZIABC011286-09)

Authors: Chandrayee Ghosh | Suresh Kumar | Yevgeniya Kushchayeva | Kelli Gaskins | Myriem Boufraqech | Darmood Wei | Sudheer Kumar Gara | Lisa Zhang | Ya-qin Zhang | Min Shen | Sanjit Mukherjee | Electron Kebebew